In 2024, the trade exchange (includes international purchases and sales) of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses was US$802M.
In 2024, the states with the most international sales in Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses were Estado de México (US$90.2M), Jalisco (US$13.4M), Ciudad de México (US$12.7M), Querétaro (US$545k), and Yucatán (US$378k).
The states with the most international purchases in 2024 were Ciudad de México (US$585M), Estado de México (US$81.5M), Jalisco (US$7.01M), and Querétaro (US$308k).
In 2024, the main commercial destinations of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses were Colombia (US$69.8M), Panama (US$8.82M), Germany (US$6.45M), Chile (US$6.02M), and Brazil (US$5.52M).
The main commercial origins of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses in 2024 were Denmark (US$221M), United States (US$145M), Germany (US$51.9M), France (US$46.8M), and Italy (US$44.2M).
In the global context, the main exporting countries of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses in 2022 were Denmark (US$8.72B), Italy (US$4.45B), and Germany (US$3.99B). In the same year, the main importing countries of Medicaments Containing Hormones or Steroids Used as Hormones but not Antibiotics, in Measured Doses were United States (US$11.7B), Switzerland (US$3.72B), and Italy (US$2.48B).